...
首页> 外文期刊>BMC Genetics >Effect of lentivirus-mediated shRNA inactivation of HK1, HK2, and HK3 genes in colorectal cancer and melanoma cells
【24h】

Effect of lentivirus-mediated shRNA inactivation of HK1, HK2, and HK3 genes in colorectal cancer and melanoma cells

机译:慢病毒介导的sh1,HK1,HK2和HK3基因shRNA失活在大肠癌和黑色素瘤细胞中的作用

获取原文
           

摘要

Background The switch from oxidative phosphorylation to glycolysis in proliferating cancer cells, even under aerobic conditions, has been shown first in 1926 by Otto Warburg. Today this phenomenon is known as the “Warburg effect” and recognized as a hallmark of cancer. The metabolic shift to glycolysis is associated with the alterations in signaling pathways involved in energy metabolism, including glucose uptake and fermentation, and regulation of mitochondrial functions. Hexokinases (HKs), which catalyze the first step of glycolysis, have been identified to play a role in tumorigenesis of human colorectal cancer (CRC) and melanoma. However, the mechanism of action of HKs in the promotion of tumor growth remains unclear. Results The purpose of the present study was to investigate the effect of silencing of hexokinase genes ( HK1 , HK2 , and HK3 ) in colorectal cancer (HT-29, SW 480, HCT-15, RKO, and HCT 116) and melanoma (MDA-MB-435S and SK-MEL-28) cell lines using short hairpin RNA (shRNA) lentiviral vectors. shRNA lentiviral plasmid vectors pLSLP-HK1, pLSLP-HK2, and pLSLP-HK3 were constructed and then transfected separately or co-transfected into the cells. HK2 inactivation was associated with increased expression of HK1 in colorectal cancer cell lines pointing to the compensation effect. Simultaneous attenuation of HK1 and HK2 levels led to decreased cell viability. Co-transfection with shRNA vectors against HK1 , HK2 , and HK3 mRNAs resulted in a rapid cell death via apoptosis. Conclusions We have demonstrated that simultaneous inactivation of HK1 and HK2 was sufficient to decrease proliferation and viability of melanoma and colorectal cancer cells. Our results suggest that HK1 and HK2 could be the key therapeutic targets for reducing aerobic glycolysis in examined cancers.
机译:背景技术奥托·沃伯格(Otto Warburg)于1926年首先证明了即使在有氧条件下,在增殖的癌细胞中也从氧化磷酸化转变为糖酵解。今天,这种现象被称为“沃堡效应”,并被认为是癌症的标志。代谢向糖酵解的转变与能量代谢所涉及的信号传导途径的改变有关,包括葡萄糖的摄取和发酵以及线粒体功能的调节。已发现,催化糖酵解第一步的己糖激酶(HKs)在人类大肠癌(CRC)和黑色素瘤的肿瘤发生中起作用。但是,HKs促进肿瘤生长的作用机制仍不清楚。结果本研究的目的是研究沉默己糖激酶基因(HK1,HK2和HK3)在结直肠癌(HT-29,SW 480,HCT-15,RKO和HCT 116)和黑素瘤(MDA)中的作用-MB-435S和SK-MEL-28细胞系,使用短发夹RNA(shRNA)慢病毒载体。构建shRNA慢病毒质粒载体pLSLP-HK1,pLSLP-HK2和pLSLP-HK3,然后分别转染或共转染到细胞中。 HK2失活与大肠癌细胞系中HK1表达的增加有关,这表明补偿作用。 HK1和HK2水平的同时衰减导致细胞活力下降。与针对HK1,HK2和HK3 mRNA的shRNA载体共转染导致细胞通过凋亡迅速死亡。结论我们已经证明,同时灭活HK1和HK2足以降低黑素瘤和结肠直肠癌细胞的增殖和生存能力。我们的结果表明,HK1和HK2可能是减少所检查癌症中有氧糖酵解的关键治疗靶标。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号